Summary
IMRT has an important role in improving dose
distributions and reducing doses to OAR in
paediatric patients
Need to consider effects on growing tissues and
balance the risks and benefits
Studies with short follow up have not confirmed
a rise in second malignancies
Needs prospective evaluation and long term
follow up
43